Lecanemab's benefits are too small and uncertain
- PMID: 39299732
- DOI: 10.1136/bmj.q2044
Lecanemab's benefits are too small and uncertain
Conflict of interest statement
Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The author declares no other interests. Further details of The BMJ policy on financial interests are here: https://www.bmj.com/about-bmj/resources-authors/forms-policies-and-checklists/declaration-competing-interests.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources